Skip to Content

RPR 202 (Riluzole 50 mg)

Pill with imprint RPR 202 is White, Capsule-shape and has been identified as Riluzole 50 mg. It is supplied by Rising Pharmaceuticals, Inc..

Riluzole is used in the treatment of amyotrophic lateral sclerosis and belongs to the drug class miscellaneous central nervous system agents. Risk cannot be ruled out during pregnancy. Riluzole 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RPR 202

Riluzole

Imprint
RPR 202
Strength
50 mg
Color
White
Size
10.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous central nervous system agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Rising Pharmaceuticals, Inc.
National Drug Code (NDC)
64980-0191
Inactive Ingredients
calcium phosphate dibasic anhydrous, microcrystalline cellulose, silicon dioxide, magnesium stearate, croscarmellose sodium, hypromelloses, polyethylene glycol 6000, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "RPR 202"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.